Cullinan Therapeutics, Inc. (CGEM) Balance Sheet
As of 2026-06-30 (10-Q), Cullinan Therapeutics, Inc. (CGEM) reported total assets of $363.8M, total liabilities of $42.0M and shareholders' equity of $321.8M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $78.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CGEMCullinan Therapeutics, Inc.Follow CGEM — free
—
Price chart with a free account
- Market cap
- 924.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 59.8 | 156.2 | 98.4 | 83.0 | 88.3 | 78.6 | |
| Short-term investments | 230.7 | 311.1 | 368.6 | 316.0 | 289.6 | 255.9 | |
| Current assets | 296.6 | 474.5 | 480.2 | 414.7 | 386.8 | 342.0 | |
| Total assets | 437.2 | 561.1 | 484.2 | 621.8 | 448.4 | 363.8 | |
| Current liabilities | 11.7 | 22.5 | 28.1 | 30.6 | 37.7 | 40.6 | |
| Total liabilities | 11.8 | 26.1 | 30.3 | 31.5 | 39.6 | 42.0 | |
| Shareholders' equity | 425.0 | 535.0 | 453.9 | 590.3 | 408.7 | 321.8 |
USD millions · SEC XBRL
Cullinan Therapeutics, Inc. — questions
- How much cash does Cullinan Therapeutics, Inc. have?
- $78.6M in cash and cash equivalents as of 2026-06-30.
- What are Cullinan Therapeutics, Inc.'s total assets?
- $363.8M as of 2026-06-30.
- What is Cullinan Therapeutics, Inc.'s shareholders' equity?
- $321.8M as of 2026-06-30.
Every figure on this page comes from Cullinan Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.